Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma

BackgroundThe prognostic value of ground glass opacity (GGO) in stage IA non-small cell lung cancer (NSCLC) has been widely recognized. However, studies investigating its value in the related stage IB–IIA lung adenocarcinoma (LUAD) remains lacking. The impact of adjuvant chemotherapy (ACT) on pathol...

Full description

Bibliographic Details
Main Authors: Wenyu Zhai, Li Gong, Yuzhen Zheng, Qihang Yan, Renchun Lai, Dachuan Liang, Wingshing Wong, Shuqin Dai, Junye Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
lung adenocarcinoma
ground glass opacity
adjuvant chemotherapy
nomogram
personalized therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.851276/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.851276/full

Similar Items